Trial Profile
A Two Part, Phase I-IIa Study Evaluating MK1775 in Combination With Topotecan/Cisplatin in Adult Patients With Cervical Cancer
Status:
Discontinued
Phase of Trial:
Phase I/II
Latest Information Update: 20 Sep 2023
Price :
$35
*
At a glance
- Drugs Adavosertib (Primary) ; Cisplatin; Topotecan
- Indications Cervical cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors Merck Sharp & Dohme Corp.
- 02 Apr 2022 This trial has been completed in France, according to European Clinical Trials Database record.
- 05 May 2011 Planned End Date changed from 1 Aug 2011 to 1 Oct 2011 as reported by ClinicalTrials.gov.
- 04 Mar 2011 Status changed from recruiting to active, no longer recruiting.